QUINSAIR
Drug
Horizon Pharma plc
Total Payments
$182,044
Transactions
19
Doctors
9
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $12.22 | 1 | 1 |
| 2018 | $151,499 | 5 | 2 |
| 2017 | $30,532 | 13 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $175,934 | 6 | 96.6% |
| Honoraria | $3,813 | 5 | 2.1% |
| Travel and Lodging | $1,151 | 2 | 0.6% |
| Food and Beverage | $1,146 | 6 | 0.6% |
Top Doctors Receiving Payments for QUINSAIR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Rheumatology | Boston, MA | $175,197 | 5 |
| , MD | Pulmonary Disease | Tyler, TX | $3,003 | 4 |
| , MD | Pulmonary Disease | Charleston, SC | $1,652 | 4 |
| , M.D | Pediatric Pulmonology | Denver, CO | $750.00 | 1 |
| Christopher Goss | Pulmonary Disease | Seattle, WA | $750.00 | 1 |
| , MD | Infectious Disease | Portland, OR | $226.70 | 1 |
| Anne Odonnell | Critical Care Medicine | Washington, DC | $226.70 | 1 |
| , MD | Critical Care Medicine | Denver, CO | $226.70 | 1 |
| , MD | Family Medicine | Montgomery, AL | $12.22 | 1 |
Ad
Manufacturing Companies
- Horizon Pharma plc $182,032
- Horizon Therapeutics plc $12.22
Product Information
- Type Drug
- Total Payments $182,044
- Total Doctors 9
- Transactions 19
About QUINSAIR
QUINSAIR is a drug associated with $182,044 in payments to 9 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Horizon Pharma plc.
Payment data is available from 2017 to 2020. In 2020, $12.22 was paid across 1 transactions to 1 doctors.
The most common payment nature for QUINSAIR is "Consulting Fee" ($175,934, 96.6% of total).